Nearly 700 people, all of whom are suing drug maker GlaxoSmithKline in three separate lawsuits alleging severe adverse events connected with the diabetes medication Avandia, are settling with the company for nearly $60 million. Avandia, also known as rosiglitazone maleate, was developed to treat type 2 diabetes mellitus. First approved by the FDA in 1999, the agency reported eight years later a significant increase in the risk of heart attack in those patients to whom Avandia had been prescribed. Thus far a number of deaths have been linked to Avandia. More recently, two independent studies showed that bone fractures, particularly in female patients, have been associated with this popular diabetes drug, while a third study has found a link between Avandia and liver failure. It was alleged in the lawsuits that the Plaintiffs suffered heart attacks, strokes, and congestive heart failure as a result of taking the drug.
Source: Lawyers & Settlements
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.